We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.5B
AUM Growth
-$232M
Cap. Flow
-$540M
Cap. Flow %
-2.92%
Top 10 Hldgs %
27.76%
Holding
3,069
New
24
Increased
234
Reduced
2,759
Closed
38

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$41.7M
2
DOCU
DocuSign
DOCU
+$18.2M
3
APO icon
Apollo Global Management
APO
+$17.5M
4
FLEX icon
Flex
FLEX
+$16.1M
5
WDAY icon
Workday
WDAY
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 29.77%
2 Financials 13.35%
3 Consumer Discretionary 11.87%
4 Industrials 10.17%
5 Healthcare 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIGL icon
2351
Rigel Pharmaceuticals
RIGL
$882M
$146K ﹤0.01%
8,653
-654
-7% -$12.5K
YMAB
2352
DELISTED
Y-mAbs Therapeutics
YMAB
$145K ﹤0.01%
18,577
-1,089
-6% -$13.3K
SLDP icon
2353
Solid Power
SLDP
$577M
$145K ﹤0.01%
76,948
-4,923
-6% -$6.09K
INBK icon
2354
First Internet Bancorp
INBK
$245M
$145K ﹤0.01%
4,036
-305
-7% -$11.6K
FULC icon
2355
Fulcrum Therapeutics
FULC
$290M
$145K ﹤0.01%
30,850
-2,329
-7% -$8.59K
DSP icon
2356
Viant Technology
DSP
$266M
$145K ﹤0.01%
7,615
-698
-8% -$10.9K
HNRG icon
2357
Hallador Energy
HNRG
$723M
$144K ﹤0.01%
12,583
-950
-7% -$10.6K
TE
2358
T1 Energy
TE
$1.36B
$144K ﹤0.01%
55,738
-4,207
-7% -$7.06K
KALV
2359
DELISTED
KalVista Pharmaceuticals
KALV
$144K ﹤0.01%
16,945
-3,682
-18% -$38.1K
MBI icon
2360
MBIA
MBI
$237M
$143K ﹤0.01%
22,189
-1,674
-7% -$8.63K
AIP icon
2361
Arteris
AIP
$1.12B
$143K ﹤0.01%
14,036
-718
-5% -$5.93K
NGS icon
2362
Natural Gas Services Group
NGS
$488M
$143K ﹤0.01%
5,333
-402
-7% -$9.43K
SOFI icon
2363
SoFi Technologies
SOFI
$22.4B
$143K ﹤0.01%
9,268
-317
-3% -$4.12K
GLUE icon
2364
Monte Rosa Therapeutics
GLUE
$1.2B
$142K ﹤0.01%
20,533
-1,550
-7% -$11.6K
PSTL
2365
Postal Realty Trust
PSTL
$702M
$142K ﹤0.01%
10,916
-597
-5% -$8.37K
UPB
2366
Upstream Bio Inc
UPB
$314M
$142K ﹤0.01%
+8,660
New +$193K
ANAB icon
2367
AnaptysBio
ANAB
$1.6B
$142K ﹤0.01%
10,747
+285
+3% +$6.9K
TBCH
2368
Turtle Beach Corp
TBCH
$229M
$142K ﹤0.01%
8,216
-948
-10% -$15.5K
CZFS icon
2369
Citizens Financial Services
CZFS
$395M
$142K ﹤0.01%
2,267
-172
-7% -$11K
RGP icon
2370
Resources Connection
RGP
$137M
$142K ﹤0.01%
16,645
-655
-4% -$5.52K
SES icon
2371
SES AI
SES
$197M
$142K ﹤0.01%
64,748
-4,888
-7% -$2.79K
ECG
2372
Everus Construction Group
ECG
$6.1B
$141K ﹤0.01%
+2,150
New +$135K
OBT icon
2373
Orange County Bancorp
OBT
$513M
$141K ﹤0.01%
5,082
-382
-7% -$11K
BAP icon
2374
Credicorp
BAP
$30B
$141K ﹤0.01%
769
MGTX icon
2375
MeiraGTx Holdings
MGTX
$1.23B
$141K ﹤0.01%
23,147
+2,405
+12% +$14.1K

Similar funds

Corebridge Financial's Q4 2024 Portfolio in Review

As of Q4 2024, Corebridge Financial held 3,069 positions worth $18.5B, down 1.2% from $18.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 2%. Corebridge Financial opened 24 new positions and exited 38, leaving the 3,069-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Corebridge Financial's largest Q4 2024 buy was Apollo Global Management: 110,177 shares worth $18.2M.
  • Corebridge Financial added most to iShares MSCI EAFE ETF in Q4 2024, an estimated $41.7M increase.
  • Corebridge Financial's biggest Q4 2024 reduction was Apple, cutting an estimated $36.8M.
  • Corebridge Financial fully exited Southwestern Energy Company in Q4 2024, selling an estimated $9.27M.
  • Corebridge Financial's ten largest holdings make up 28% of its $18.5B portfolio in Q4 2024.
  • Corebridge Financial opened 24 new positions and closed 38 in Q4 2024.
  • Corebridge Financial's portfolio value fell 1.2% quarter-over-quarter to $18.5B.

Based on Corebridge Financial's 13F filing for Q4 2024, filed 11 Feb 2025.